<p>Coldstream Capital Management Inc. 在最近向美国证券交易委员会提交的 13F 表格中披露，在第二季度将其在 H. B. Fuller Company (NYSE:FUL - 免费报告) 的持股比例提高了 712.2%。该机构投资者在此期间额外购买了 5,484 股后，持有该特种化学公司 6,254 股股票。截至最近向美国证券交易委员会的提交，Coldstream Capital Management Inc. 在 H. B. Fuller 的持股价值为 376,000 美元。</p>
<ul>
<li>工业化学品：三只在新年有增长潜力的股票</li>
</ul>
<p>其他大型投资者也调整了对该公司的持股。Partners Capital Investment Group LLP 在第一季度将其在 H. B. Fuller 的持股比例提高了 90.3%。Partners Capital Investment Group LLP 目前拥有 64,901 股该特种化学公司的股票，价值 3,642,000 美元，此前在上个季度额外购买了 30,805 股。Entropy Technologies LP 在第一季度购买了 H. B. Fuller 的新头寸，价值约 581,000 美元。Vanguard Personalized Indexing Management LLC 在第二季度将其在 H. B. Fuller 的持股提高了 12.2%。Vanguard Personalized Indexing Management LLC 目前拥有 9,904 股该特种化学公司的股票，价值 596,000 美元，此前在此期间额外获得了 1,077 股。QRG Capital Management Inc. 在第二季度将其在 H. B. Fuller 的持股提高了 19.1%。QRG Capital Management Inc. 目前拥有 8,147 股该特种化学公司的股票，价值 490,000 美元，此前在上个季度额外获得了 1,309 股。最后，Quantbot Technologies LP 在第一季度将其在 H. B. Fuller 的持股提高了 612.4%。Quantbot Technologies LP 目前拥有 28,083 股该特种化学公司的股票，价值 1,576,000 美元，此前在此期间额外购买了 24,141 股。95.93% 的股票由机构投资者持有。</p>
<h2>华尔街分析师预测增长</h2>
<p>几位分析师对 FUL 股票发布了报告。花旗集团在 10 月 22 日的研究报告中将 H. B. Fuller 的股票评级从 “中性” 上调至 “买入”，并将其目标价从 62.00 美元提高至 70.00 美元。Seaport Res Ptn 在 9 月 26 日的研究报告中将 H. B. Fuller 的评级从 “持有” 上调至 “强力买入”。Weiss Ratings 在 11 月 17 日的研究报告中重申了对 H. B. Fuller 股票的 “持有 (c)” 评级。瑞银集团在 11 月 21 日的研究报告中开始覆盖 H. B. Fuller，给予 “中性” 评级和 60.00 美元的目标价。最后，Wall Street Zen 在 11 月 24 日的研究报告中将 H. B. Fuller 的股票评级从 “买入” 下调至 “持有”。两位股票研究分析师给予该股票 “强力买入” 评级，三位给予 “买入” 评级，三位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “适度买入”，共识目标价为 66.20 美元。</p>
<ul>
<li>Acuity Brands 在工业领域的机会</li>
</ul>
<p><strong>查看我们关于 H. B. Fuller 的最新研究报告</strong></p>
<h2>H. B. Fuller 的内部交易</h2>
<p>在 H. B. Fuller 的其他新闻中，首席财务官 John J. Corkrean 于 10 月 27 日星期一出售了 14,222 股股票。该股票以平均价格 60.31 美元出售，总交易额为 857,728.82 美元。交易后，首席财务官在公司中持有 54,646 股，价值 3,295,700.26 美元。这笔交易代表了他们持股比例的 20.65% 的减少。该销售在向美国证券交易委员会提交的文件中披露，文件可在美国证券交易委员会网站上获取。此外，副总裁 Nathan D. Weaver 于 11 月 13 日星期四出售了 7,075 股 H. B. Fuller 股票。该股票以平均价格 58.38 美元出售，总交易额为 413,038.50 美元。交易完成后，副总裁直接持有 9,441 股公司股票，价值约 551,165.58 美元。这代表了他们持股比例的 42.84% 的减少。该销售的披露信息可在美国证券交易委员会的文件中找到。公司内部人士持有该公司 1.99% 的股票。</p>
<h2>H. B. Fuller 价格表现</h2>
<ul>
<li>股息之王 H.B. Fuller 在反弹希望中上涨</li>
</ul>
<p>FUL 股票在周五开盘价为 58.28 美元。该公司的债务与股本比率为 1.06，速动比率为 1.18，流动比率为 1.93。该公司的市值为 31.5 亿美元，市盈率为 31.50，市盈增长比率为 1.05，贝塔系数为 1.13。该公司的 50 日移动平均价格为 58.38 美元，200 日移动平均价格为 58.61 美元。H. B. Fuller Company 的 12 个月低点为 47.56 美元，12 个月高点为 77.77 美元。</p>
<p>H. B. Fuller (NYSE:FUL - 获取免费报告) 最近在 4 月 13 日星期三发布了其财报。该特种化学公司报告本季度每股收益为 0.66 美元。该公司在本季度的收入为 7.259 亿美元。H. B. Fuller 的净利润率为 3.28%，股本回报率为 11.49%。H. B. Fuller 已设定其 2022 财年的指导目标为每股收益 4.100-4.350 美元。整体而言，研究分析师预计 H. B. Fuller Company 本财年将发布每股收益 4.07 美元。</p>
<h2>H. B. Fuller 股息公告</h2>
<p>该公司最近还宣布了季度股息，将于 10 月 30 日星期四支付。10 月 16 日星期四的股东获得每股 0.235 美元的股息。这代表了每年 0.94 美元的股息和 1.6% 的股息收益率。除息日期为 10 月 16 日星期四。H. B. Fuller 的股息支付比率为 50.81%。</p>
<h2>H. B. Fuller 公司简介</h2>
<p>(免费报告)</p>
<p>H.B. 富勒公司及其子公司专注于配方、制造和销售粘合剂、密封剂、涂料、高分子材料、胶带、封装材料、添加剂及其他特种化学产品。它通过三个部门运营：卫生、健康和消费粘合剂；工程粘合剂；以及建筑粘合剂。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过 H.B. 富勒</li>
<li>三只值得购买和持有的医疗保健分红股票</li>
<li>持续发力：应用数字公司的首个 AI 数据中心上线</li>
<li>如何最有效地使用 MarketBeat 盈利筛选器</li>
<li>字母表：最有可能主导 2026 年的 AI 领导者</li>
<li>顶尖生物科技股票：探索创新机会</li>
<li>加仓 Fiserv 的两个理由，远离的一个理由</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZVTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZVTA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 在 H.B. 富勒 吗？</h2>
<p>在考虑 H.B. 富勒 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 H.B. 富勒 并不在名单上。</p>
<p>虽然 H.B. 富勒目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HB富勒

<p>Coldstream Capital Management Inc. 在第二季度将其在 H. B. Fuller Company 的股份增加了 712.2%。分析师对 FUL 股票的评级意见不一，普遍评级为 “适度买入”，目标价格为 66.20 美元。内部交易包括首席财务官 John J. Corkrean 和副总裁 Nathan D. Weaver 的股票出售。FUL 股票开盘价为 58.28 美元，市值为 31.5 亿美元</p>

<p>Coldstream Capital Management Inc. raised its stake in H. B. Fuller Company (NYSE:FUL - Free Report) by 712.2% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,254 shares of the specialty chemicals company's stock after buying an additional 5,484 shares during the period. Coldstream Capital Management Inc.'s holdings in H. B. Fuller were worth $376,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>Coldstream Capital Management Inc. 在最近向美国证券交易委员会提交的 13F 表格中披露，在第二季度将其在 H. B. Fuller Company (NYSE:FUL - 免费报告) 的持股比例提高了 712.2%。该机构投资者在此期间额外购买了 5,484 股后，持有该特种化学公司 6,254 股股票。截至最近向美国证券交易委员会的提交，Coldstream Capital Management Inc. 在 H. B. Fuller 的持股价值为 376,000 美元。</p>
</div><ul>
<li>Industrial Chemicals: 3 Stocks Poised for Growth in the New Year</li>
</ul>
<div class="lb-trans"><ul>
<li>工业化学品：三只在新年有增长潜力的股票</li>
</ul>
</div><p>Other large investors have also modified their holdings of the company. Partners Capital Investment Group LLP lifted its stake in H. B. Fuller by 90.3% during the first quarter. Partners Capital Investment Group LLP now owns 64,901 shares of the specialty chemicals company's stock valued at $3,642,000 after buying an additional 30,805 shares in the last quarter. Entropy Technologies LP purchased a new position in shares of H. B. Fuller in the first quarter worth approximately $581,000. Vanguard Personalized Indexing Management LLC raised its holdings in shares of H. B. Fuller by 12.2% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 9,904 shares of the specialty chemicals company's stock valued at $596,000 after acquiring an additional 1,077 shares during the period. QRG Capital Management Inc. lifted its position in shares of H. B. Fuller by 19.1% in the 2nd quarter. QRG Capital Management Inc. now owns 8,147 shares of the specialty chemicals company's stock valued at $490,000 after acquiring an additional 1,309 shares in the last quarter. Finally, Quantbot Technologies LP boosted its stake in H. B. Fuller by 612.4% in the 1st quarter. Quantbot Technologies LP now owns 28,083 shares of the specialty chemicals company's stock worth $1,576,000 after purchasing an additional 24,141 shares during the period. 95.93% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他大型投资者也调整了对该公司的持股。Partners Capital Investment Group LLP 在第一季度将其在 H. B. Fuller 的持股比例提高了 90.3%。Partners Capital Investment Group LLP 目前拥有 64,901 股该特种化学公司的股票，价值 3,642,000 美元，此前在上个季度额外购买了 30,805 股。Entropy Technologies LP 在第一季度购买了 H. B. Fuller 的新头寸，价值约 581,000 美元。Vanguard Personalized Indexing Management LLC 在第二季度将其在 H. B. Fuller 的持股提高了 12.2%。Vanguard Personalized Indexing Management LLC 目前拥有 9,904 股该特种化学公司的股票，价值 596,000 美元，此前在此期间额外获得了 1,077 股。QRG Capital Management Inc. 在第二季度将其在 H. B. Fuller 的持股提高了 19.1%。QRG Capital Management Inc. 目前拥有 8,147 股该特种化学公司的股票，价值 490,000 美元，此前在上个季度额外获得了 1,309 股。最后，Quantbot Technologies LP 在第一季度将其在 H. B. Fuller 的持股提高了 612.4%。Quantbot Technologies LP 目前拥有 28,083 股该特种化学公司的股票，价值 1,576,000 美元，此前在此期间额外购买了 24,141 股。95.93% 的股票由机构投资者持有。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several analysts have issued reports on FUL shares. Citigroup raised shares of H. B. Fuller from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and boosted their target price for the company from $62.00 to $70.00 in a research note on Wednesday, October 22nd. Seaport Res Ptn raised H. B. Fuller from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Friday, September 26th. Weiss Ratings restated a &#34;hold (c)&#34; rating on shares of H. B. Fuller in a research report on Monday, November 17th. UBS Group initiated coverage on H. B. Fuller in a research note on Friday, November 21st. They set a &#34;neutral&#34; rating and a $60.00 target price on the stock. Finally, Wall Street Zen lowered shares of H. B. Fuller from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, November 24th. Two equities research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $66.20.</p>
<div class="lb-trans"><p>几位分析师对 FUL 股票发布了报告。花旗集团在 10 月 22 日的研究报告中将 H. B. Fuller 的股票评级从 “中性” 上调至 “买入”，并将其目标价从 62.00 美元提高至 70.00 美元。Seaport Res Ptn 在 9 月 26 日的研究报告中将 H. B. Fuller 的评级从 “持有” 上调至 “强力买入”。Weiss Ratings 在 11 月 17 日的研究报告中重申了对 H. B. Fuller 股票的 “持有 (c)” 评级。瑞银集团在 11 月 21 日的研究报告中开始覆盖 H. B. Fuller，给予 “中性” 评级和 60.00 美元的目标价。最后，Wall Street Zen 在 11 月 24 日的研究报告中将 H. B. Fuller 的股票评级从 “买入” 下调至 “持有”。两位股票研究分析师给予该股票 “强力买入” 评级，三位给予 “买入” 评级，三位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “适度买入”，共识目标价为 66.20 美元。</p>
</div><ul>
<li>Acuity Brands Lights Up Opportunity In The Industrial Sector</li>
</ul>
<div class="lb-trans"><ul>
<li>Acuity Brands 在工业领域的机会</li>
</ul>
</div><p><strong>Check Out Our Latest Research Report on H. B. Fuller</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 H. B. Fuller 的最新研究报告</strong></p>
</div><h2>Insider Transactions at H. B. Fuller</h2>
<div class="lb-trans"><h2>H. B. Fuller 的内部交易</h2>
</div><p>In other H. B. Fuller news, CFO John J. Corkrean sold 14,222 shares of the stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $60.31, for a total transaction of $857,728.82. Following the transaction, the chief financial officer owned 54,646 shares in the company, valued at $3,295,700.26. This trade represents a 20.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Nathan D. Weaver sold 7,075 shares of H. B. Fuller stock in a transaction that occurred on Thursday, November 13th. The shares were sold at an average price of $58.38, for a total transaction of $413,038.50. Following the completion of the transaction, the vice president directly owned 9,441 shares in the company, valued at approximately $551,165.58. This represents a 42.84% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.99% of the company's stock.</p>
<div class="lb-trans"><p>在 H. B. Fuller 的其他新闻中，首席财务官 John J. Corkrean 于 10 月 27 日星期一出售了 14,222 股股票。该股票以平均价格 60.31 美元出售，总交易额为 857,728.82 美元。交易后，首席财务官在公司中持有 54,646 股，价值 3,295,700.26 美元。这笔交易代表了他们持股比例的 20.65% 的减少。该销售在向美国证券交易委员会提交的文件中披露，文件可在美国证券交易委员会网站上获取。此外，副总裁 Nathan D. Weaver 于 11 月 13 日星期四出售了 7,075 股 H. B. Fuller 股票。该股票以平均价格 58.38 美元出售，总交易额为 413,038.50 美元。交易完成后，副总裁直接持有 9,441 股公司股票，价值约 551,165.58 美元。这代表了他们持股比例的 42.84% 的减少。该销售的披露信息可在美国证券交易委员会的文件中找到。公司内部人士持有该公司 1.99% 的股票。</p>
</div><h2>H. B. Fuller Price Performance</h2>
<div class="lb-trans"><h2>H. B. Fuller 价格表现</h2>
</div><ul>
<li>Dividend King H.B. Fuller Rises On Hopes For Rebound</li>
</ul>
<div class="lb-trans"><ul>
<li>股息之王 H.B. Fuller 在反弹希望中上涨</li>
</ul>
</div><p>Shares of FUL opened at $58.28 on Friday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.18 and a current ratio of 1.93. The firm has a market cap of $3.15 billion, a PE ratio of 31.50, a PEG ratio of 1.05 and a beta of 1.13. The firm's 50 day moving average price is $58.38 and its 200 day moving average price is $58.61. H. B. Fuller Company has a twelve month low of $47.56 and a twelve month high of $77.77.</p>
<div class="lb-trans"><p>FUL 股票在周五开盘价为 58.28 美元。该公司的债务与股本比率为 1.06，速动比率为 1.18，流动比率为 1.93。该公司的市值为 31.5 亿美元，市盈率为 31.50，市盈增长比率为 1.05，贝塔系数为 1.13。该公司的 50 日移动平均价格为 58.38 美元，200 日移动平均价格为 58.61 美元。H. B. Fuller Company 的 12 个月低点为 47.56 美元，12 个月高点为 77.77 美元。</p>
</div><p>H. B. Fuller (NYSE:FUL - Get Free Report) last posted its earnings results on Wednesday, April 13th. The specialty chemicals company reported $0.66 EPS for the quarter. The company had revenue of $725.90 million during the quarter. H. B. Fuller had a net margin of 3.28% and a return on equity of 11.49%. H. B. Fuller has set its FY 2022 guidance at $4.100-$4.350 EPS. As a group, research analysts expect that H. B. Fuller Company will post 4.07 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>H. B. Fuller (NYSE:FUL - 获取免费报告) 最近在 4 月 13 日星期三发布了其财报。该特种化学公司报告本季度每股收益为 0.66 美元。该公司在本季度的收入为 7.259 亿美元。H. B. Fuller 的净利润率为 3.28%，股本回报率为 11.49%。H. B. Fuller 已设定其 2022 财年的指导目标为每股收益 4.100-4.350 美元。整体而言，研究分析师预计 H. B. Fuller Company 本财年将发布每股收益 4.07 美元。</p>
</div><h2>H. B. Fuller Dividend Announcement</h2>
<div class="lb-trans"><h2>H. B. Fuller 股息公告</h2>
</div><p>The business also recently declared a quarterly dividend, which was paid on Thursday, October 30th. Stockholders of record on Thursday, October 16th were paid a dividend of $0.235 per share. This represents a $0.94 annualized dividend and a dividend yield of 1.6%. The ex-dividend date was Thursday, October 16th. H. B. Fuller's dividend payout ratio is 50.81%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度股息，将于 10 月 30 日星期四支付。10 月 16 日星期四的股东获得每股 0.235 美元的股息。这代表了每年 0.94 美元的股息和 1.6% 的股息收益率。除息日期为 10 月 16 日星期四。H. B. Fuller 的股息支付比率为 50.81%。</p>
</div><h2>H. B. Fuller Company Profile</h2>
<div class="lb-trans"><h2>H. B. Fuller 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.</p>
<div class="lb-trans"><p>H.B. 富勒公司及其子公司专注于配方、制造和销售粘合剂、密封剂、涂料、高分子材料、胶带、封装材料、添加剂及其他特种化学产品。它通过三个部门运营：卫生、健康和消费粘合剂；工程粘合剂；以及建筑粘合剂。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than H. B. Fuller</li>
<li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li>
<li>Power On: Applied Digital’s First AI Data Center Goes Live</li>
<li>How to Most Effectively Use the MarketBeat Earnings Screener</li>
<li>Alphabet: The AI Leader Best Positioned to Dominate 2026</li>
<li>Top Biotech Stocks: Exploring Innovation Opportunities</li>
<li>2 Reasons to Load Up on Fiserv, 1 to Stay Away</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 H.B. 富勒</li>
<li>三只值得购买和持有的医疗保健分红股票</li>
<li>持续发力：应用数字公司的首个 AI 数据中心上线</li>
<li>如何最有效地使用 MarketBeat 盈利筛选器</li>
<li>字母表：最有可能主导 2026 年的 AI 领导者</li>
<li>顶尖生物科技股票：探索创新机会</li>
<li>加仓 Fiserv 的两个理由，远离的一个理由</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZVTA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=FUL"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in H. B. Fuller Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 H.B. 富勒 吗？</h2>
</div><p>Before you consider H. B. Fuller, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 H.B. 富勒 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H. B. Fuller wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 H.B. 富勒 并不在名单上。</p>
</div><p>While H. B. Fuller currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 H.B. 富勒目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Coldstream Capital Management Inc.增加了在 HB 富勒公司$FUL 的头寸